You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic; epithelial; virus; advanced

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, Epithelial Tumor Trial in United States (NG-641)

Recruiting
  • Metastatic Cancer
  • Epithelial Tumor
  • NG-641
  • Los Angeles, California
  • +5 more
Jan 16, 2023

Epithelial Tumors, Malignant Trial in Randwick (MT-302 (A))

Recruiting
  • Epithelial Tumors, Malignant
  • MT-302 (A)
  • Randwick, New South Wales, Australia
    Scientia Clinical Research Ltd
Aug 1, 2023

Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
  • (no location specified)
Jun 12, 2023

Locally Advanced or Metastatic Epithelial Tumor Trial in Guangzhou (SI-B001)

Active, not recruiting
  • Locally Advanced or Metastatic Epithelial Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 14, 2022

Solid Tumor Trial (OH2 Injection)

Not yet recruiting
  • Solid Tumor
  • OH2 Injection
  • (no location specified)
Jul 12, 2023

Metastatic Cancer, Epithelial Tumor Trial in Santa Monica, Liverpool, Oxford (NG-641 in combination with Nivolumab)

Recruiting
  • Metastatic Cancer
  • Epithelial Tumor
  • NG-641 in combination with Nivolumab
  • Santa Monica, California
  • +2 more
Mar 16, 2022

Epithelial Tumor, Metastatic Cancer Trial in United Kingdom, United States (NG-350A plus Pembrolizumab)

Recruiting
  • Epithelial Tumor
  • Metastatic Cancer
  • NG-350A plus Pembrolizumab
  • Santa Monica, California
  • +3 more
May 4, 2022

Assess Safety and Effectiveness of Zirabev in Domestic Various

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +7 more
  • (no location specified)
Jun 30, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

Recruiting
  • Advanced Ovarian Carcinoma
  • +7 more
  • Bydgoszcz, Kujawsko-pomorskie, Poland
  • +2 more
Mar 7, 2023

Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

Completed
  • Carcinoma
  • +12 more
  • Ocoxin-Viusid
  • Havana, Cuba
    National Institute of Oncology and Radiobiology (INOR)
Jul 5, 2022

Advanced Bladder Carcinoma Trial in Wuhan (OH2 injection)

Recruiting
  • Advanced Bladder Carcinoma
  • OH2 injection
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College of Huazhong University o
Aug 5, 2022

Solid Tumor Trial (BS006 Injection)

Not yet recruiting
  • Solid Tumor
  • BS006 Injection
  • (no location specified)
Jul 3, 2023

Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

Not yet recruiting
  • Advanced Fallopian Tube Carcinoma
  • +10 more
  • Wee1 Inhibitor ZN-c3
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 25, 2023

Solid Tumor, Solid Carcinoma, Solid Tumor, Adult Trial in Duarte, Detroit, Fairfax (CF33-hNIS, Pembrolizumab)

Recruiting
  • Solid Tumor
  • +4 more
  • CF33-hNIS
  • Pembrolizumab
  • Duarte, California
  • +2 more
Aug 1, 2022

Non-squamous NSCLC, Epithelial Ovarian Cancer Trial (AMG 794)

Not yet recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • Epithelial Ovarian Cancer
  • AMG 794
  • Orange, California
    University of California at Irvine
Jan 25, 2023

Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

Not yet recruiting
  • Head and Neck Cancer
  • +8 more
  • Tumor and HLA Profiling
  • (no location specified)
Mar 31, 2023

Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma Trial in United States (CBX-12)

Recruiting
  • Solid Tumor, Adult
  • +11 more
  • New Haven, Connecticut
  • +3 more
May 9, 2022

Ovarian Cancer Trial in Pittsburgh (Carboplatin AUC 5 and paclitaxel, Bintrafusp alfa (M7824))

Not yet recruiting
  • Ovarian Cancer
  • Carboplatin AUC 5 and paclitaxel
  • Bintrafusp alfa (M7824)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jul 12, 2022

Colorectal Cancer, Squamous Cell Carcinoma of the Head and Neck, Epithelial Tumor Trial in United States (enadenotucirev,

Completed
  • Colorectal Cancer
  • +2 more
  • enadenotucirev
  • nivolumab
  • Tucson, Arizona
  • +5 more
Nov 2, 2021

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

Completed
  • Male Breast Cancer
  • +7 more
  • propranolol hydrochloride
  • Correlative Studies
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 4, 2022

Recurrent/Metastatic Gastric Cancer Trial in Seoul (Nivolumab, Paclitaxel)

Completed
  • Recurrent/Metastatic Gastric Cancer
  • Nivolumab, Paclitaxel
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Sep 9, 2022

Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +9 more
  • Saint Louis, Missouri
  • +4 more
Dec 12, 2022

Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • ASP9801
  • Pembrolizumab
  • Birmingham, Alabama
  • +26 more
Jan 6, 2023

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023